ADHD Drugs Market By Drug Type (Stimulant, Non-stimulant) By Age-Group (Adult (Aged 18 and above), Children) By Distribution Channel (Retail Pharmacy, Hospital Pharmacy): Growth, Future Prospects, and Competitive Analysis, 2015 - 2027

The Attention-Deficit Hyperactivity Disorder (ADHD) Drugs Market is expected to cross-market value of USD 34,781 million in 2027 from USD 19,523 million in 2020. It is expected to grow at a CAGR of over 8.7% during the forecast period.

Global ADHD Drugs Market

To learn how our report can help you streamline your business, Request Sample Here

Key Market Drivers and Restraints

Rising awareness regarding ADHD drugs among physicians, patients, and other healthcare providers is expected to drive the growth of the global ADHD Drugs market. Also, an increasing number of clinical trials and rising awareness regarding the diagnosis and treatment of the condition are projected to fuel the growth of the global market over the forecast period.

However, under-diagnosis of ADHD due to comorbid conditions in children, low availability, and lack of awareness of non-stimulant drugs to treat ADHD in various regions are expected to hamper the global ADHD drugs market.

Global ADHD Drugs Market

Impact of COVID 19

The Attention-Deficit Hyperactivity Disorder drug market will show considerable growth on the back of the global pandemic. As a result of the COVID-19 outburst, healthcare organizations have deprioritized the best part of non-essential medical treatments. Furthermore, with supply chain disruptions and delayed production lines, players are leveraging the demand for medicines, and are difficult to dispatch them to stores that are running out of necessary medicines.

Global ADHD Drugs Market

North America to Dominate the global ADHD Drugs Market

The global ADHD Drugs Market covers the six regions, namely Europe, North America, Asia Pacific, Latin America (LATAM), Middle East and Africa, including all the key economies in these regions. North America market is dominated the global market and accounted for more than 62.0% of the total market. This is attributed to the large volume of drug prescriptions, increasing product launches, and rising collaboration among players to enhance market penetration.

Global ADHD Drugs Market

Global ADHD Drugs Market is led by the Adult (Aged 18 and above)

Adults (Aged 18 and above), and Children, are the key age group in the ADHD Drugs Market. In 2020, the Adult (Aged 18 and above) segment accounted for the largest share of the ADHD Drugs Market. However, the Children segment is anticipated to grow at the fastest CAGR during the forecast period.

Stimulants would continue to dominate the global ADHD Drugs Market in terms of Drug Type.

Stimulants and Non-stimulant are some of the major types of drugs type. The stimulant segment accounted for the largest share 2020 of the ADHD Drugs Market 2020. Increasing demand for stimulant drugs due to their effectiveness in treating symptoms of attention-deficit disorder, government imitative for the use of stimulants, and ongoing clinical trials.

Global ADHD Drugs Market

Frequently asked questions about global ADHD drugs market

The effect is vulnerability to distress caused by the current pandemic

Stimulant and Non-stimulant are the most frequently through ADHD Drugs

Adult (Aged 18 and above) is the most age-group in ADHD Drugs

Amneal Pharmaceuticals, Inc, Eli Lilly And Company, Janssen Pharmaceuticals, Inc, Noven Pharmaceuticals, Inc, RespireRx Pharmaceuticals Inc, Otsuka Pharmaceutical Co., Ltd are key players operating in this market

Retail Pharmacy Distribution Channel offers tremendous opportunities to players

Choose License Type
Trusted By
Related Report

Published Date:  Apr 2021
Category:  Pharmaceuticals
Report ID:   60325
Report Format:   PDF
Pages:   120
Rating:    4.2 (66)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support